Jane Street Group, LLC Equillium, Inc. Transaction History
Jane Street Group, LLC
- $444 Billion
- Q4 2024
A detailed history of Jane Street Group, LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 19,754 shares of EQ stock, worth $17,383. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,754Holding current value
$17,383% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding EQ
# of Institutions
27Shares Held
11.3MCall Options Held
0Put Options Held
0-
Decheng Capital LLC Menlo Park, CA4.45MShares$3.91 Million0.71% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$3.91 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA842KShares$740,9140.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$494,804100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny261KShares$230,0320.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $30.2M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...